Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $2.8M | $2.1M | $1.6M | $1.1M | $1.8M | $5.2M | $597.0K |
| Cost of revenue | $2.3M | $1.9M | $1.5M | $1.3M | $914.0K | $1.1M | $2.0M | $657.0K |
| Gross profit | $771.0K | $939.0K | $560.0K | $344.0K | $204.0K | $679.0K | $3.2M | −$60.0K |
| Gross margin | 25.3% | 33.2% | 26.7% | 20.9% | 18.2% | 38.4% | 61.0% | -10.1% |
| R&D | $87.0K | $66.0K | $9.0K | $15.0K | $19.0K | $18.0K | $17.0K | $18.0K |
| Operating income | −$335.0K | $105.0K | −$2.0K | −$259.0K | −$603.0K | −$82.0K | $1.1M | −$1.8M |
| EBITDA | −$323.0K | $109.0K | $3.0K | −$255.0K | −$491.0K | $23.0K | $998.0K | −$1.7M |
| Net income | −$344.0K | $95.0K | −$11.0K | −$265.0K | −$499.0K | $10.0K | $885.0K | −$1.9M |
| Net margin | -11.3% | 3.4% | -0.5% | -16.1% | -44.6% | 0.6% | 17.0% | -311.1% |
| EPS (diluted) | -0.02 | 0.00 | -0.00 | -0.01 | -0.02 | 0.00 | 0.02 | -0.05 |
Annual figures · source: Financial Modeling Prep
NET MEDICAL XPS SLTNS INC
No one on the platform currently holds NMXS.
No tracked institution reports a position in NMXS as of their last filing.
| Execution date | Ratio |
|---|---|
| 2016-06-20 | 1-for-9reverse |
No one on the platform has traded NMXS yet.
| +0.00% |
| $4193 |
| — |
| LCDXCaliber Imaging & Diagnostics, Inc. | $0.00 | +0.00% | $5104 | — |
| NMRDNemaura Medical Inc. | $0.00 | +0.00% | $4035 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.